Headache for Zosano as FDA turns down migraine patch

Headache for Zosano as FDA turns down migraine patch

Source: 
Pharmaforum
snippet: 

Zosano Pharma has been hit by an FDA rejection of its marketing application for migraine drug Qtrypta, asking for new bioequivalence data.